DERMATOMYOSITIS

Clinical trials for DERMATOMYOSITIS explained in plain language.

Never miss a new study

Get alerted when new DERMATOMYOSITIS trials appear

Sign up with your email to follow new studies for DERMATOMYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 27 Not yet recruiting 4 Not yet finished but already full! 7 Completed 9 Terminated 1

Hizentra shows promise for rare muscle and skin disease

Disease control Terminated

This study tested a medicine called Hizentra (IgPro20) in 134 adults with dermatomyositis, a rare disease causing muscle weakness and skin rashes. The goal was to see if weekly shots under the skin could improve symptoms better than a placebo. The study was stopped early, but res…

Matched conditions: DERMATOMYOSITIS

Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC

DERMATOMYOSITIS

Get alerted when new DERMATOMYOSITIS trials appear

Hizentra shows promise for rare muscle and skin disease